Your Cart ( 1 Item )

• Extended Efalizumab Therapy Sustains Efficacy Without Increasing Toxicity in Patients with Moderate to Severe Chronic Plaque Psoriasis
  November 2004 | Volume 3 | Issue 6 | Original Article | 614 | Copyright © November 2004
  Alice B Gottlieb MD PhD, Kenneth B Gordon MD, Mark G Lebwohl MD, Ivor Caro MD, Patricia A Walicke MD PhD, Nicole Li PhD,Craig L Leonardi MD, for the Efalizumab Study Group
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs